Correlation Between Rekah Pharmaceutical and Nextage Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rekah Pharmaceutical and Nextage Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rekah Pharmaceutical and Nextage Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rekah Pharmaceutical Industry and Nextage Therapeutics, you can compare the effects of market volatilities on Rekah Pharmaceutical and Nextage Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rekah Pharmaceutical with a short position of Nextage Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rekah Pharmaceutical and Nextage Therapeutics.
Diversification Opportunities for Rekah Pharmaceutical and Nextage Therapeutics
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Rekah and Nextage is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Rekah Pharmaceutical Industry and Nextage Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nextage Therapeutics and Rekah Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rekah Pharmaceutical Industry are associated (or correlated) with Nextage Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nextage Therapeutics has no effect on the direction of Rekah Pharmaceutical i.e., Rekah Pharmaceutical and Nextage Therapeutics go up and down completely randomly.
Pair Corralation between Rekah Pharmaceutical and Nextage Therapeutics
Assuming the 90 days trading horizon Rekah Pharmaceutical is expected to generate 13.62 times less return on investment than Nextage Therapeutics. But when comparing it to its historical volatility, Rekah Pharmaceutical Industry is 2.58 times less risky than Nextage Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Nextage Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 5,500 in Nextage Therapeutics on September 12, 2024 and sell it today you would earn a total of 2,260 from holding Nextage Therapeutics or generate 41.09% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rekah Pharmaceutical Industry vs. Nextage Therapeutics
Performance |
| Timeline |
| Rekah Pharmaceutical |
| Nextage Therapeutics |
Rekah Pharmaceutical and Nextage Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rekah Pharmaceutical and Nextage Therapeutics
The main advantage of trading using opposite Rekah Pharmaceutical and Nextage Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rekah Pharmaceutical position performs unexpectedly, Nextage Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextage Therapeutics will offset losses from the drop in Nextage Therapeutics' long position.| Rekah Pharmaceutical vs. Kamada | Rekah Pharmaceutical vs. Bezeq Israeli Telecommunication | Rekah Pharmaceutical vs. B Communications | Rekah Pharmaceutical vs. Photomyne |
| Nextage Therapeutics vs. Ram On Investments and | Nextage Therapeutics vs. Imed Infinity Medical Limited | Nextage Therapeutics vs. Tower Semiconductor | Nextage Therapeutics vs. Isras Investment |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |